Upgrade to SI Premium - Free Trial

Insmed (INSM) PT Lowered to $185 at Truist Securities

May 13, 2026 1:06 PM
Truist Securities analyst Danielle Brill lowered the price target on Insmed (NASDAQ: INSM) to $185.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change